Robert Joseph Smith - Nov 7, 2024 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Director
Signature
/s/ Alexander M. Donaldson, by power of attorney
Stock symbol
CTXR
Transactions as of
Nov 7, 2024
Transactions value $
$0
Form type
4
Date filed
11/12/2024, 05:00 PM
Previous filing
Aug 14, 2024
Next filing
Dec 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Stock Option (Right to Purchase Common Stock) Award $0 +125K $0.00 125K Nov 7, 2024 Common Stock 125K $0.38 Direct F1
holding CTXR Stock Option (Right to Purchase Common Stock) 75K Nov 7, 2024 Common Stock 75K $0.69 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
F2 The options are vested in full and exercisable immediately.